Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

NCT02664441 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Hypothalamic Obesity

Interventions

DRUG: Exenatide
DRUG: placebo

Sponsor

Seattle Children's Hospital

Collaborators

[object Object]
[object Object]